Literature DB >> 33622467

Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients.

Jennifer H Ku, Emily M Henkle, Kathleen F Carlson, Miguel Marino, Kevin L Winthrop.   

Abstract

Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code-based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these claims have moderate validity, but given their low sensitivity, incidence might be underestimated.

Entities:  

Keywords:  Medicare claims; bacteria; bronchiectasis; nontuberculous mycobacterial infection; respiratory infections; tuberculosis and other mycobacteria; validation

Mesh：

Year:  2021        PMID： 33622467      PMCID： PMC7920682          DOI： 10.3201/eid2703.203124

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  9 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Bronchiectasis and non-tuberculous mycobacterial pulmonary infection.

Authors:  W-J Koh; O J Kwon
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 3.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

4.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

5.  The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.

Authors:  Kevin L Winthrop; Roger Baxter; Liyan Liu; Bentson McFarland; Donald Austin; Cara Varley; LeAnn Radcliffe; Eric Suhler; Dongsoek Choi; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-10       Impact factor: 2.890

6.  Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.

Authors:  Timothy R Aksamit; Anne E O'Donnell; Alan Barker; Kenneth N Olivier; Kevin L Winthrop; M Leigh Anne Daniels; Margaret Johnson; Edward Eden; David Griffith; Michael Knowles; Mark Metersky; Matthias Salathe; Byron Thomashow; Gregory Tino; Gerard Turino; Betsy Carretta; Charles L Daley
Journal:  Chest       Date:  2016-11-23       Impact factor: 9.410

7.  Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.

Authors:  Emily Henkle; Jeffrey R Curtis; Lang Chen; Benjamin Chan; Timothy R Aksamit; Charles L Daley; David E Griffith; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2019-07-18       Impact factor: 16.671

8.  Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology.

Authors:  P Maureen Cassidy; Katrina Hedberg; Ashlen Saulson; Erin McNelly; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

9.  Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.

Authors:  Ethan E Bodle; Jennifer A Cunningham; Phyllis Della-Latta; Neil W Schluger; Lisa Saiman
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883
  9 in total
  3 in total

1.  Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.

Authors:  Hsin-Hua Chen; Ching-Heng Lin; Wen-Cheng Chao
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

2.  Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes.

Authors:  Jae Hyeon Park; Sue Shin; Taek Soo Kim; Hyunwoong Park
Journal:  BMC Pulm Med       Date:  2022-05-13       Impact factor: 3.320

3.  Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.

Authors:  D Rebecca Prevots; Theodore K Marras; Ping Wang; Kevin C Mange; Patrick A Flume
Journal:  Chest       Date:  2021-07-24       Impact factor: 9.410
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.